Case Control Study
Copyright ©The Author(s) 2017.
World J Hepatol. Mar 28, 2017; 9(9): 469-476
Published online Mar 28, 2017. doi: 10.4254/wjh.v9.i9.469
Figure 3
Figure 3 Receiver operating characteristic curve analysis shows the diagnostic performance of alpha-fetoprotein and annexin A2 in the discrimination of patients with hepatocellular carcinoma from those with chronic liver disease. AFP: Alpha-fetoprotein; NDL: Non-discriminating line (Diagonal line).